HBV mutation literature information.


  "Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the ""fingers"" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene."
 PMID: 12167344       2002       Virology
Abstract: In contrast, the HBV a determinant HBIg/vaccine escape mutants sP120T, sT123N, sG145R, and sD144E/G145R (that produce rtT128N, Q130P, rtW153Q, and rtG153E respectively) yielded as much virus as wild-type HBV while the sM133L (rtY141S) mutant was replication i


  Recombinant HBsAg of the Wild-Type and the G145R Escape Mutant, included in the New Multivalent Vaccine against Hepatitis B Virus, Dramatically Differ in their Effects on Leukocytes from Healthy Donors In Vitro.
 PMID: 12457969       2002       Virus research
Abstract: As all of them were seronegative for HBsAg/antiHBc, the presence of G145R mutant in the PBL signaled possibility of spread of the vaccine escape mutant virus by blood transfusion, unsafe injection practices or through sexual root.
Abstract: The study not only establishes the persistence of surface mutant G145R HBV DNA, within the PBL of HBsAg negative individuals from the non-vaccinated random population, but also suggests possible horizontal transmission of the mutant among the family members although none of the family members has received immunoprophylaxis against HBV or had clinically apparent disease or any other known risk factors of HBV infection.
Abstract: This indicates the presence of established vaccine escape mutant of the virus ( PMID: 11264736       2001       Journal of viral hepatitis
Abstract: One child had a double mutation (P142S and G145R) and the other a G145A substitution.
Abstract: Three of seven anti-HBc positive Chinese blood donors had a T131I substitution, whilst the interferon-treated patient had a treble amino acid substitution (P142S, G145R and N146D).


  Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen.
 PMID: 11385295       2001       Journal of biomedical science
Abstract: Notably, HBsAg with an arginine replacement for glycine at amino acid 145 is considered the quintessential immune escape mutant because it has been isolated consistently in clinical samples of HBIg-treated individuals and vaccinated infants of chronically infected mothers.


  Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.
 PMID: 11395201       2001       Vaccine
1Abstract: Anti-HBs binding to synthetic peptids (25-mers, 7aa overlap) from the ""a""-loop was significantly reduced by the G145R substitution and by changing the amino acid sequence from adw(2) into adr."
Abstract: In a previous study we found that plasma-derived and recombinant DNA-derived vaccine HBsAg reacted differently with monoclonal antibodies sensitive for the G145R change.
Abstract: The G145R mutant of the small S-protein is a major escape mutant of hepatitis B virus observed in natural infection, after immunization and HBIG therapy.

Browser Board

 Co-occurred Entities




   Filtrator